Eitan Kerem

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 125 publications

Post-infectious bronchiolitis obliterans in children: pathogenesis, treatment strategies, and future directions.

Post-infectious bronchiolitis obliterans in children: pathogenesis, treatment strategies, and future directions.

Journal: Current opinion in pediatrics

Published: June 03, 2026

International Society of Pediatric Respiratory Diseases (INSPiRED) call to action: A Global Ban on Electronic Cigarette Sales to Protect our Children's Future.

International Society of Pediatric Respiratory Diseases (INSPiRED) call to action: A Global Ban on Electronic Cigarette Sales to Protect our Children's Future.

Journal: Paediatric respiratory reviews

Published: May 19, 2026

Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.

Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.

Journal: Nature communications

Published: February 27, 2026

Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry.

Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry.

Journal: The Lancet. Respiratory medicine

Published: January 06, 2026

Henry Levison, a Giant of Pediatric Respiratory Medicine.

Henry Levison, a Giant of Pediatric Respiratory Medicine.

Journal: Pediatric pulmonology

Published: December 29, 2025

Intestinal organoids as a platform for functional evaluation of ASO-mediated splicing modulation in cystic fibrosis.

Intestinal organoids as a platform for functional evaluation of ASO-mediated splicing modulation in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: August 27, 2025

Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry.

Factors associated with sustained Pseudomonas aeruginosa infection following elexacaftor/tezacaftor/ivacaftor treatment: Real-world data from the European cystic fibrosis society patient registry.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: June 10, 2025

Long-term outcomes in people with CF lacking FEV1 response to elexacaftor/tezacaftor/ivacaftor therapy.

Long-term outcomes in people with CF lacking FEV1 response to elexacaftor/tezacaftor/ivacaftor therapy.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 18, 2025

Health inequity in people with cystic fibrosis: can we close the gap?

Health inequity in people with cystic fibrosis: can we close the gap?

Journal: Annals of the American Thoracic Society

Published: January 14, 2025

The response of rare CFTR mutations to specific modulator combinations.

The response of rare CFTR mutations to specific modulator combinations.

Journal: ERJ open research

Published: December 08, 2024

Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry.

Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry.

Journal: ERJ open research

Published: November 26, 2024

Global Pediatric Pulmonology Alliance recommendations to protect all infants against respiratory syncytial virus with prophylactic monoclonal antibodies.

Global Pediatric Pulmonology Alliance recommendations to protect all infants against respiratory syncytial virus with prophylactic monoclonal antibodies.

Journal: Pediatric investigation

Published: October 22, 2024

Showing 1-12 of 125

Last Updated: 09/26/2026